EPS and EP-Link Initiatives Featured in Newsweek Country Reports
The initiatives of EPS Corporation and EP-Link Co., Ltd. have been featured in a special report published in Newsweek Country Reports under the theme, How Japan Is Accelerating Medical Innovation and Patient Access.
The report highlights various efforts aimed at addressing challenges facing Japan’s healthcare system, including an aging population, shortages of healthcare professionals, drug lag, and drug loss, while strengthening the connections among research and development, clinical trials, and healthcare delivery.
EPS Corporation was featured for its initiatives centered on EPS BIOPath, an integrated support service for domestic and international biotechnology and pharmaceutical companies seeking to enter the Japanese market. The service provides comprehensive support across regulatory strategy, development planning, biostatistics, project management, and clinical trial execution.
Featured Article
How Japan Is Accelerating Medical Innovation and Patient Access
EP-Link Co., Ltd. was also featured for its initiatives leveraging its nationwide network of medical institutions and Clinical Research Coordinators (CRCs), as well as its Patient LINK and SYNOV-R services. Through these initiatives, EP-Link supports more efficient patient recruitment, the digitalization of clinical trials, and improvements in the clinical trial environment and drug development process.
The initiatives of both companies were introduced as examples of efforts in Japan aimed at accelerating access to innovative medicines and medical technologies for patients.
The EPS Group will continue contributing to medical innovation by supporting the development of pharmaceuticals and medical devices, connecting innovation in Japan with the global healthcare community, and creating new value for patients worldwide.
Related Links
Newsweek Country Reports
EPS BIOPath
EP-Link Services & Solutions
Contact Us
Share this page